Hengsai Biotechnology
China's First! Hengsai Bio's Original DC Vaccine KSD-101 Receives FDA IND Approval
241China's First! Hengsai Bio's Original DC Vaccine KSD-101 Receives FDA IND Approval
View details
Search the whole station
China's First! Hengsai Bio's Original DC Vaccine KSD-101 Receives FDA IND Approval
View details
Hengsai Biologicals Completes Tens of Millions of Dollars in Series A+ Financing
View details
Hengsai Bio USA - San Diego The 65th Annual Meeting of the American Society of Hematology (ASH) was grandly held in San Diego, USA on December 9-12, 2023. As the largest, most numerous and most influential annual meeting in the field of international hematology, this year's ASH Congress gathered 35,000 specialists and scholars from 109 countries and regions around the world to present their latest achievements, exchange ...
View details Hengsai Biologicals Completes $100 Million Series A Financing, with MaiPai Capital as Exclusive Financial Advisor
View details